400
Participants
Start Date
December 5, 2025
Primary Completion Date
February 26, 2032
Study Completion Date
September 2, 2036
Zongertinib
Zongertinib
Pembrolizumab
Pembrolizumab
Atezolizumab
Atezolizumab
Durvalumab
Durvalumab
Nivolumab
Nivolumab
Tri-Service General Hospital, Taipei
Chang Gung Memorial Hospital Linkou, Taoyuan
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Centro de Investigaciones Médicas y Desarrollo LC S.R.L. (LC Investigación), CABA
Clinic Floridsdorf, Vienna
Centro Oncologico Korben, CABA
Clinica Adventista Belgrano, CABA
Edegem - UNIV UZ Antwerpen, Edegem
UZ Leuven, Leuven
Centre Hospitalier Universitaire de Liège, Liège
Sjællands Universitetshospital, Roskilde
Hospital Universitario De Burgos, Burgos
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
AOU San Luigi Gonzaga, Orbassano (TO)
National Taiwan University Hospital, Taipei
Memorial Sloan-Kettering Cancer Center, New York
National Cancer Center, Goyang
Taipei Veterans General Hospital, Taipei
Hospital Jerez de la Frontera, Jerez de la Frontera
Henry Dunant Hospital, Athens, Athens
"Chest Hospital of Athens Sotiria", Athens
National Cancer Institute, Cairo University, Cairo
University General Hospital Attikon, Athens
Seoul National University Bundang Hospital, Seongnam
Centro de Infusion Profesional Integral (CIPI), Mexico City
The Catholic University of Korea, St.Vincent's Hospital, Suwon
Ajou University Hospital, Suwon
George Washington University Cancer Center, Washington D.C.
Istituto Clinico Humanitas, Rozzano (MI)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Virginia Cancer Specialists, PC, Fairfax
LungenClinic Grosshansdorf GmbH, Großhansdorf
Pius-Hospital, Oldenburg, Oldenburg
Hospital Universitario Ramon Y Cajal, Madrid
Fundación Jiménez Díaz, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Puerta de Hierro, Madrid
Hospital Virgen de la Victoria, Málaga
Tianjin Medical University General Hospital, Tianjin
Northwest Georgia Oncology Centers, Marietta
Piedmont Cancer Institute, Atlanta
Complejo Hospitalario de Navarra, Pamplona
HOP Larrey, Toulouse
Mid Florida Hematology and Oncology Center, Orange City
HOP Pontchaillou, Rennes
Azienda Ospedaliera Universitaria Integrata Verona, Verona
China Medical University Hospital, Taichung
Hospital Virgen del Rocío, Seville
Salut Sant Joan de Reus, Reus
HOP Nord Laennec, Nantes
Meir Medical Center, Kfar Saba
Centro Oncologico Internacional, Jalisco
Hospital Clínico de Valencia, Valencia
Universitätsklinikum Köln (AöR), Cologne
Northwestern University, Chicago
University of Illinois Hospital and Health Sciences System, Chicago
Varisano LungenZentrum (VLZ), Frankfurt
Centro Medico Zambrano Hellion, Monterrey
Centre Régional de Lutte Contre le Cancer Paul Stauss, Strasbourg
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg
HOP Louis Pradel, Bron
Istituto Tumori Giovanni Paolo II, Bari
Klinikum Esslingen, Esslingen am Neckar
Hendrick Health, Abilene
Istituto Nazionale IRCCS Tumori Fondazione Pascale, Napoli
Asklepios Fachkliniken München-Gauting, Gauting
Saint Alphonsus Regional Medical Center - Boise, Boise
Community Cancer Trials of Utah, Ogden
Cancer Care Specialists, Reno
University of California Los Angeles, Santa Monica
Premier Cancer Care, Fresno
Northern California Kaiser Permanente, Vallejo
INS Gustave Roussy, Villejuif
Humanitas Istituto Clinico Catanese S.p.A., Misterbianco (CT)
Universitätsklinikum Würzburg AÖR, Würzburg
Providence Cancer Institute, Portland
China-Japan Friendship Hospital, Beijing
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
The First Affiliated Hospital of Soochow University, Suzhou
Affiliated Hospital, Xuzhou Medical college, Xuzhou
Northern Jiangsu People's Hospital, Yangzhou
Shandong Cancer Hospital, Jinan
Linyi Cancer Hospital, Linyi
Tianjin Cancer Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University, Hangzhou
Taizhou Hospital of Zhejiang Province, Taizhou
The First Affiliated Hospital of Nanchang University, Nanchang
Polaris Medical S.A., Suceagu/ Cluj Napoca
Wuhan Union Hospital, Wuhan
Sichuan Cancer Hospital, Chengdu
West China Hospital of Sichuan University, Chengdu
Yunnan Provincial Tumor Hospital, Kunming
Ovidius Clinical Hospital S.R.L, Ovidiu
Rambam Health Care Campus, Haifa
Sheba Medical Center, Ramat Gan
Sourasky Medical Center, Tel Aviv
Bradford Hill- Centro de Investigación Clínica, Recoleta
Shaare Zedek Medical Center, Jerusalem 91031, Jerusalem
Dana-Farber Cancer Institute, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Hospital Britanico de Buenos Aires, CABA
Instituto Medico Especializado Alexander Fleming, Capital Federal
Hospital de Amor, Barretos
NewData Clinical Research - Maceió, Maceió
Centro de Pesquisa Oncology Natal, Natal
Centro Gaúcho Integrado de Oncologia, Hematologia, Ensino e Pesquisa, Porto Alegre
CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia, Santo André
ICESP - Instituto do Cancer do Estado de Sao Paulo, São Paulo
A.C. Camargo, São Paulo
Princess Margaret Cancer Centre, Toronto
Centro de Estudios Clinicos SAGA, Providencia
Hebei Provincial Tumor Hospital, Shijiazhuang
Shefaa El Orman Oncology Hospital, Luxor
Queen Mary Hospital, Hong Kong
Sağlık Bilimleri Üniversitesi Gülhane Eğitim ve Araştırma Hastanesi, Ankara
Istituti Fisioterapici Ospitalieri, Roma
Aichi Cancer Center Hospital, Aichi, Nagoya
Fujita Health University Hospital, Aichi, Toyoake
National Cancer Center Hospital East, Chiba, Kashiwa
Kyushu University Hospital, Fukuoka, Fukuoka
Hospital of the University of Occupational and Environmental Health, Fukuoka, Kitakyushu
Hiroshima University Hospital, Hiroshima, Hiroshima
Hokkaido Cancer Center, Hokkaido, Sapporo
Kitasato University Hospital, Kanagawa, Sagamihara
Kanagawa Cancer Center, Kanagawa, Yokohama
Sendai Kousei Hospital, Miyagi, Sendai
Niigata Cancer Center Hospital, Niigata, Niigata
Okayama University Hospital, Okayama, Okayama
Kansai Medical University Hospital, Osaka, Hirakata
Kindai University Hospital, Osaka, Osakasayama
Osaka International Cancer Institute, Osaka, Osaka
National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Sakai
Saitama Medical University International Medical Center, Saitama, Hidaka
Saitama Cancer Center, Saitama, Kitaadachi-gun
Shizuoka Cancer Center, Shizuoka, Sunto-gun
Jichi Medical University Hospital, Tochigi, Shimotsuke
Juntendo University Hospital, Tokyo, Bunkyo-ku
National Cancer Center Hospital, Tokyo, Chuo-ku
Japanese Foundation for Cancer Research, Tokyo, Koto-ku
Tokyo Medical University Hospital, Tokyo, Shinjuku-ku
Wakayama Medical University Hospital, Wakayama, Wakayama
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Amsterdam (METC AVL), Amsterdam
Hospital CUF Tejo, Lisbon
Hospital da Luz, Lisbon
Hospital CUF Porto, Porto
IPO Porto Francisco Gentil, EPE, Porto
Lotus Med, Bucharest
Memorial Healthcare International, Bucharest
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital del Mar, Barcelona
Hospital Vall Hebron, Barcelona
Hospital General Universitario de Elche, Elche
Hospital Duran i Reynals, L'Hospitalet de Llobregat
Sahlgrenska Universitetsjukhuset, Gothenburg
Karolinska Universitetssjukhuset Solna, Stockholm
Lead Sponsor
Boehringer Ingelheim
INDUSTRY